Price movement over the last 24 hours
Ares Capital Corporation vs Synopsys, Inc. — how do they compare? Ares Capital Corporation trades at $18.77 (market cap $13.48B), while Synopsys, Inc. trades at $446.84 (market cap $85.30B). The key difference: Synopsys, Inc. is far larger — about 6.3× Ares Capital Corporation's market cap, and Ares Capital Corporation pays a 10.22% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals.
| ARCC | SNPS | |
|---|---|---|
Market Cap | $13.48B | $85.30B |
Sector | Financials | Technology |
52-Week High | $23.25 | $645.59 |
52-Week Low | $17.45 | $380.47 |
Dividend Yield | 10.22% | — |
Enterprise Value | — | $93.66B |
Signals from Pluang's Aura AI — not financial advice
Ares Capital (ARCC) trades at $18.78, up 2.01% on the day, with a bearish technical signal but strong analyst support. The stock shows a P/E of 11.52 and P/B of 0.96, trading below the consensus price target of $20.58. Recent earnings have missed expectations, with Q2 2026 results pending, while revenue declined to $1.51B in 2025 from $1.7B in 2024. A dividend of $0.48 is scheduled for payment on June 30, 2026, supporting income appeal amid mixed sentiment.
ARCC presents a value opportunity with a high dividend yield and undervaluation relative to analyst targets, but faces headwinds from earnings misses and a bearish technical outlook. Risks include revenue volatility and competitive pressures in the BDC space, though institutional buy ratings suggest confidence in recovery potential. Investors should weigh income stability against growth challenges.
Synopsys (SNPS) trades at $445.40, up 0.5% on the day, amid a bearish technical signal with support at $432 and resistance at $449. The stock shows strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $3.35 versus $3.15 expected, and robust revenue growth to $7.05B in 2025. However, net income margin declined to 8.91% from 36.93% in 2024, and cash flow turned negative at -$1.01B due to heavy investing activity.
Outlook remains positive with analyst consensus price target of $558.33 implying 25% upside, supported by the company's strategic pivot to AI-driven design tools. Key risks include execution of the AI transition, high valuation multiples like a P/E of 101.95, and semiconductor cycle volatility. The stock offers growth exposure but requires monitoring of margin trends and competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →